Cargando…

Progress in Multidisciplinary Treatment of Fournier’s Gangrene

Fournier’s gangrene (FG) is a life-threatening and special form of necrotizing fasciitis, characterized by occult onset, rapid progress and high mortality, occurring mainly in men over 50 years of age. Risk factors of FG include diabetes, HIV infection, chronic alcoholism and other immunosuppressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ke-Fan, Shi, Chuan-Xin, Chen, Si-Yu, Wei, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717591/
https://www.ncbi.nlm.nih.gov/pubmed/36465810
http://dx.doi.org/10.2147/IDR.S390008
_version_ 1784842932867563520
author Zhang, Ke-Fan
Shi, Chuan-Xin
Chen, Si-Yu
Wei, Wei
author_facet Zhang, Ke-Fan
Shi, Chuan-Xin
Chen, Si-Yu
Wei, Wei
author_sort Zhang, Ke-Fan
collection PubMed
description Fournier’s gangrene (FG) is a life-threatening and special form of necrotizing fasciitis, characterized by occult onset, rapid progress and high mortality, occurring mainly in men over 50 years of age. Risk factors of FG include diabetes, HIV infection, chronic alcoholism and other immunosuppressive state. FG was previously considered as an idiopathic disease, but in fact, three quarters of the infections originated from the skin, urethra and gastrointestinal tract. Initial symptoms of FG are often inconsistent with severity and can progress promptly to fatal infection. Although the treatment measures of FG have been improved in recent years, the mortality does not seem to have decreased significantly and remains at 20% – 30%. The time to identify FG and the waiting period before surgical debridement are directly related to the prognosis. Therefore, in addition to the combination of intensive fluid resuscitation and broad-spectrum antibiotics, treatment of FG should particularly emphasize the importance of early surgical debridement assisted with fecal diversion and skin reconstruction when necessary. This paper is to briefly summarize the progress in the definition, epidemiology, clinical manifestations, diagnosis, treatment and prognosis of Fournier’s gangrene in recent years, more importantly, illustrates the importance of multidisciplinary cooperation in the management of FG.
format Online
Article
Text
id pubmed-9717591
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-97175912022-12-03 Progress in Multidisciplinary Treatment of Fournier’s Gangrene Zhang, Ke-Fan Shi, Chuan-Xin Chen, Si-Yu Wei, Wei Infect Drug Resist Review Fournier’s gangrene (FG) is a life-threatening and special form of necrotizing fasciitis, characterized by occult onset, rapid progress and high mortality, occurring mainly in men over 50 years of age. Risk factors of FG include diabetes, HIV infection, chronic alcoholism and other immunosuppressive state. FG was previously considered as an idiopathic disease, but in fact, three quarters of the infections originated from the skin, urethra and gastrointestinal tract. Initial symptoms of FG are often inconsistent with severity and can progress promptly to fatal infection. Although the treatment measures of FG have been improved in recent years, the mortality does not seem to have decreased significantly and remains at 20% – 30%. The time to identify FG and the waiting period before surgical debridement are directly related to the prognosis. Therefore, in addition to the combination of intensive fluid resuscitation and broad-spectrum antibiotics, treatment of FG should particularly emphasize the importance of early surgical debridement assisted with fecal diversion and skin reconstruction when necessary. This paper is to briefly summarize the progress in the definition, epidemiology, clinical manifestations, diagnosis, treatment and prognosis of Fournier’s gangrene in recent years, more importantly, illustrates the importance of multidisciplinary cooperation in the management of FG. Dove 2022-11-28 /pmc/articles/PMC9717591/ /pubmed/36465810 http://dx.doi.org/10.2147/IDR.S390008 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Zhang, Ke-Fan
Shi, Chuan-Xin
Chen, Si-Yu
Wei, Wei
Progress in Multidisciplinary Treatment of Fournier’s Gangrene
title Progress in Multidisciplinary Treatment of Fournier’s Gangrene
title_full Progress in Multidisciplinary Treatment of Fournier’s Gangrene
title_fullStr Progress in Multidisciplinary Treatment of Fournier’s Gangrene
title_full_unstemmed Progress in Multidisciplinary Treatment of Fournier’s Gangrene
title_short Progress in Multidisciplinary Treatment of Fournier’s Gangrene
title_sort progress in multidisciplinary treatment of fournier’s gangrene
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717591/
https://www.ncbi.nlm.nih.gov/pubmed/36465810
http://dx.doi.org/10.2147/IDR.S390008
work_keys_str_mv AT zhangkefan progressinmultidisciplinarytreatmentoffourniersgangrene
AT shichuanxin progressinmultidisciplinarytreatmentoffourniersgangrene
AT chensiyu progressinmultidisciplinarytreatmentoffourniersgangrene
AT weiwei progressinmultidisciplinarytreatmentoffourniersgangrene